Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Nivolumab vid behandling av patienter med ihållande, återkommande eller metastaserad livmoderhalscancer

16 november 2026 uppdaterad av: National Cancer Institute (NCI)

En fas II-utvärdering av Nivolumab, en helt mänsklig antikropp mot PD-1, vid behandling av ihållande eller återkommande livmoderhalscancer

This phase II trial studies the side effects and how well nivolumab works in treating patients with cervical cancer that has grown, come back, or spread to other places in the body. Monoclonal antibodies, such as nivolumab, may block tumor growth in different ways by targeting certain cells.

Studieöversikt

Status

Aktiv, inte rekryterande

Betingelser

Intervention / Behandling

Detaljerad beskrivning

PRIMARY OBJECTIVES:

I. To assess the antitumor activity (proportion of objective response by Response Evaluation Criteria in Solid Tumors [RECIST] 1.1 criteria) of nivolumab with objective tumor response in patients with persistent, recurrent or metastatic carcinoma of the cervix.

II. To determine the nature and degree of toxicity of nivolumab as assessed by Common Terminology Criteria for Adverse Events (CTCAE) in patients with persistent, recurrent or metastatic carcinoma of the cervix.

SECONDARY OBJECTIVES:

I. To estimate the duration of progression-free survival (PFS) and overall survival (OS).

TERTIARY OBJECTIVES:

I. To systematically evaluate programmed cell death (PD)-1 and B7 homolog 1 (B7-H1) (i.e., PD-1 ligand) expression in tumor infiltrating lymphocytes (TILs) and cervical cancer cells and explore their correlations with objective response, PFS, and OS in nivolumab-treated patients with PD-1 and B7-H1 scoring results.

II. To explore the composition of immune infiltrates in tumor specimens/biopsies from primary and/or metastatic/recurrent sites with selected markers including (but not limited) to cluster of differentiation (CD)4+, CD8+, forkhead box P3 (FoxP3), CD25, lymphocyte activation gene-3 (LAG-3), T cell immunoglobulin mucin-3 (TIM-3), and inducible T-cell co-stimulator (ICOS) and their correlations to objective response, PFS and OS in nivolumab-treated patients.

III. To evaluate human papillomavirus (HPV) status and to explore the changes of pre- and post-immune therapy responses to HPV16/18/31/35/45 E7 antigens in patients peripheral blood lymphocytes (PBL) and serum using proliferative and interferon (IFN)-gamma enzyme-linked immunospot (ELISPOT) (cellular immunity) and serological (enzyme-linked immunosorbent assay [ELISA]) assays.

IV. To explore the levels of circulating tumor cells (CTCs) pre-treatment and at 8 and 12 weeks and their association with patient outcome.

OUTLINE:

Patients receive nivolumab intravenously (IV) over approximately 60 minutes every 2 weeks for a maximum of 46 doses over 92 weeks in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 3 years.

Studietyp

Interventionell

Inskrivning (Faktisk)

26

Fas

  • Fas 2

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Alabama
      • Birmingham, Alabama, Förenta staterna, 35233
        • University of Alabama at Birmingham Cancer Center
    • Alaska
      • Anchorage, Alaska, Förenta staterna, 98508
        • Anchorage Associates in Radiation Medicine
      • Anchorage, Alaska, Förenta staterna, 99508
        • Alaska Breast Care and Surgery LLC
      • Anchorage, Alaska, Förenta staterna, 99508
        • Alaska Oncology and Hematology LLC
      • Anchorage, Alaska, Förenta staterna, 99508
        • Alaska Women's Cancer Care
      • Anchorage, Alaska, Förenta staterna, 99508
        • Anchorage Oncology Centre
      • Anchorage, Alaska, Förenta staterna, 99508
        • Katmai Oncology Group
      • Anchorage, Alaska, Förenta staterna, 99508
        • Providence Alaska Medical Center
      • Anchorage, Alaska, Förenta staterna, 99504
        • Anchorage Radiation Therapy Center
      • Anchorage, Alaska, Förenta staterna, 99508
        • Alaska Regional Hospital
    • Arkansas
      • Hot Springs, Arkansas, Förenta staterna, 71913
        • CHI Saint Vincent Cancer Center Hot Springs
    • California
      • Auburn, California, Förenta staterna, 95602
        • Sutter Auburn Faith Hospital
      • Auburn, California, Förenta staterna, 95603
        • Sutter Cancer Centers Radiation Oncology Services-Auburn
      • Baldwin Park, California, Förenta staterna, 91706
        • Kaiser Permanente-Baldwin Park
      • Berkeley, California, Förenta staterna, 94704
        • Alta Bates Summit Medical Center-Herrick Campus
      • Burbank, California, Förenta staterna, 91505
        • Providence Saint Joseph Medical Center/Disney Family Cancer Center
      • Burlingame, California, Förenta staterna, 94010
        • Mills-Peninsula Medical Center
      • Cameron Park, California, Förenta staterna, 95682
        • Sutter Cancer Centers Radiation Oncology Services-Cameron Park
      • Castro Valley, California, Förenta staterna, 94546
        • Eden Hospital Medical Center
      • Davis, California, Förenta staterna, 95616
        • Sutter Davis Hospital
      • La Jolla, California, Förenta staterna, 92093
        • UC San Diego Moores Cancer Center
      • Modesto, California, Förenta staterna, 95355
        • Memorial Medical Center
      • Mountain View, California, Förenta staterna, 94040
        • Palo Alto Medical Foundation-Camino Division
      • Mountain View, California, Förenta staterna, 94040
        • Palo Alto Medical Foundation-Gynecologic Oncology
      • Palo Alto, California, Förenta staterna, 94301
        • Palo Alto Medical Foundation Health Care
      • Roseville, California, Förenta staterna, 95661
        • Sutter Cancer Centers Radiation Oncology Services-Roseville
      • Roseville, California, Förenta staterna, 95661
        • Sutter Roseville Medical Center
      • Sacramento, California, Förenta staterna, 95816
        • Sutter Medical Center Sacramento
      • San Diego, California, Förenta staterna, 92120
        • Kaiser Permanente-San Diego Zion
      • San Diego, California, Förenta staterna, 92108
        • Kaiser Permanente-Rio San Diego
      • San Francisco, California, Förenta staterna, 94115
        • California Pacific Medical Center-Pacific Campus
      • San Marcos, California, Förenta staterna, 92078
        • Kaiser Permanente-San Marcos
      • Santa Cruz, California, Förenta staterna, 95065
        • Palo Alto Medical Foundation-Santa Cruz
      • Santa Rosa, California, Förenta staterna, 95403
        • Sutter Pacific Medical Foundation
      • Sunnyvale, California, Förenta staterna, 94086
        • Palo Alto Medical Foundation-Sunnyvale
      • Vallejo, California, Förenta staterna, 94589
        • Sutter Solano Medical Center/Cancer Center
    • Connecticut
      • New Haven, Connecticut, Förenta staterna, 06520
        • Yale University
    • Delaware
      • Lewes, Delaware, Förenta staterna, 19958
        • Beebe Medical Center
      • Newark, Delaware, Förenta staterna, 19713
        • Helen F Graham Cancer Center
      • Newark, Delaware, Förenta staterna, 19713
        • Delaware Clinical and Laboratory Physicians PA
      • Newark, Delaware, Förenta staterna, 19713
        • Medical Oncology Hematology Consultants PA
      • Newark, Delaware, Förenta staterna, 19718
        • Christiana Care Health System-Christiana Hospital
      • Rehoboth Beach, Delaware, Förenta staterna, 19971
        • Beebe Health Campus
      • Seaford, Delaware, Förenta staterna, 19973
        • TidalHealth Nanticoke / Allen Cancer Center
      • Wilmington, Delaware, Förenta staterna, 19801
        • Christiana Care Health System-Wilmington Hospital
    • Georgia
      • Savannah, Georgia, Förenta staterna, 31405
        • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
      • Savannah, Georgia, Förenta staterna, 31404
        • Memorial Health University Medical Center
      • Savannah, Georgia, Förenta staterna, 31404
        • Summit Cancer Care-Memorial
      • Savannah, Georgia, Förenta staterna, 31404
        • Low Country Cancer Care
    • Idaho
      • Boise, Idaho, Förenta staterna, 83712
        • Saint Luke's Cancer Institute - Boise
      • Coeur d'Alene, Idaho, Förenta staterna, 83814
        • Kootenai Health - Coeur d'Alene
      • Fruitland, Idaho, Förenta staterna, 83619
        • Saint Luke's Cancer Institute - Fruitland
      • Meridian, Idaho, Förenta staterna, 83642
        • Saint Luke's Cancer Institute - Meridian
      • Nampa, Idaho, Förenta staterna, 83687
        • Saint Luke's Cancer Institute - Nampa
      • Post Falls, Idaho, Förenta staterna, 83854
        • Kootenai Clinic Cancer Services - Post Falls
      • Sandpoint, Idaho, Förenta staterna, 83864
        • Kootenai Clinic Cancer Services - Sandpoint
      • Twin Falls, Idaho, Förenta staterna, 83301
        • Saint Luke's Cancer Institute - Twin Falls
    • Illinois
      • Bloomington, Illinois, Förenta staterna, 61704
        • Illinois CancerCare-Bloomington
      • Bloomington, Illinois, Förenta staterna, 61701
        • OSF Saint Joseph Medical Center
      • Canton, Illinois, Förenta staterna, 61520
        • Illinois CancerCare-Canton
      • Carbondale, Illinois, Förenta staterna, 62902
        • Memorial Hospital of Carbondale
      • Carthage, Illinois, Förenta staterna, 62321
        • Illinois CancerCare-Carthage
      • Centralia, Illinois, Förenta staterna, 62801
        • Centralia Oncology Clinic
      • Chicago, Illinois, Förenta staterna, 60611
        • Northwestern University
      • Decatur, Illinois, Förenta staterna, 62526
        • Decatur Memorial Hospital
      • Decatur, Illinois, Förenta staterna, 62526
        • Cancer Care Specialists of Illinois - Decatur
      • Effingham, Illinois, Förenta staterna, 62401
        • Crossroads Cancer Center
      • Eureka, Illinois, Förenta staterna, 61530
        • Illinois CancerCare-Eureka
      • Galesburg, Illinois, Förenta staterna, 61401
        • Western Illinois Cancer Treatment Center
      • Galesburg, Illinois, Förenta staterna, 61401
        • Illinois CancerCare-Galesburg
      • Hinsdale, Illinois, Förenta staterna, 60521
        • Sudarshan K Sharma MD Limited-Gynecologic Oncology
      • Kewanee, Illinois, Förenta staterna, 61443
        • Illinois CancerCare-Kewanee Clinic
      • Macomb, Illinois, Förenta staterna, 61455
        • Illinois CancerCare-Macomb
      • Mount Vernon, Illinois, Förenta staterna, 62864
        • SSM Health Good Samaritan
      • O'Fallon, Illinois, Förenta staterna, 62269
        • Cancer Care Center of O'Fallon
      • Ottawa, Illinois, Förenta staterna, 61350
        • Illinois CancerCare-Ottawa Clinic
      • Ottawa, Illinois, Förenta staterna, 61350
        • Radiation Oncology of Northern Illinois
      • Pekin, Illinois, Förenta staterna, 61554
        • Illinois CancerCare-Pekin
      • Pekin, Illinois, Förenta staterna, 61554
        • OSF Saint Francis Radiation Oncology at Pekin
      • Peoria, Illinois, Förenta staterna, 61636
        • Methodist Medical Center of Illinois
      • Peoria, Illinois, Förenta staterna, 61637
        • OSF Saint Francis Medical Center
      • Peoria, Illinois, Förenta staterna, 61615
        • Illinois CancerCare-Peoria
      • Peoria, Illinois, Förenta staterna, 61615
        • OSF Saint Francis Radiation Oncology at Peoria Cancer Center
      • Peru, Illinois, Förenta staterna, 61354
        • Illinois CancerCare-Peru
      • Peru, Illinois, Förenta staterna, 61354
        • Valley Radiation Oncology
      • Princeton, Illinois, Förenta staterna, 61356
        • Illinois CancerCare-Princeton
      • Springfield, Illinois, Förenta staterna, 62702
        • Southern Illinois University School of Medicine
      • Springfield, Illinois, Förenta staterna, 62702
        • Springfield Clinic
      • Springfield, Illinois, Förenta staterna, 62702
        • Central Illinois Hematology Oncology Center
      • Springfield, Illinois, Förenta staterna, 62781
        • Springfield Memorial Hospital
    • Indiana
      • Indianapolis, Indiana, Förenta staterna, 46202
        • Indiana University/Melvin and Bren Simon Cancer Center
      • Indianapolis, Indiana, Förenta staterna, 46202
        • Sidney and Lois Eskenazi Hospital
      • Richmond, Indiana, Förenta staterna, 47374
        • Reid Health
    • Iowa
      • Clive, Iowa, Förenta staterna, 50325
        • Mercy Cancer Center-West Lakes
      • Clive, Iowa, Förenta staterna, 50325
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
      • Council Bluffs, Iowa, Förenta staterna, 51503
        • Alegent Health Mercy Hospital
      • Creston, Iowa, Förenta staterna, 50801
        • Greater Regional Medical Center
      • Des Moines, Iowa, Förenta staterna, 50314
        • Mercy Medical Center - Des Moines
      • Des Moines, Iowa, Förenta staterna, 50314
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
      • Iowa City, Iowa, Förenta staterna, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
      • West Des Moines, Iowa, Förenta staterna, 50266
        • Mercy Medical Center-West Lakes
    • Kansas
      • Chanute, Kansas, Förenta staterna, 66720
        • Cancer Center of Kansas - Chanute
      • Dodge City, Kansas, Förenta staterna, 67801
        • Cancer Center of Kansas - Dodge City
      • El Dorado, Kansas, Förenta staterna, 67042
        • Cancer Center of Kansas - El Dorado
      • Fort Scott, Kansas, Förenta staterna, 66701
        • Cancer Center of Kansas - Fort Scott
      • Independence, Kansas, Förenta staterna, 67301
        • Cancer Center of Kansas-Independence
      • Kingman, Kansas, Förenta staterna, 67068
        • Cancer Center of Kansas-Kingman
      • Lawrence, Kansas, Förenta staterna, 66044
        • Lawrence Memorial Hospital
      • Liberal, Kansas, Förenta staterna, 67905
        • Cancer Center of Kansas-Liberal
      • Newton, Kansas, Förenta staterna, 67114
        • Cancer Center of Kansas - Newton
      • Parsons, Kansas, Förenta staterna, 67357
        • Cancer Center of Kansas - Parsons
      • Pratt, Kansas, Förenta staterna, 67124
        • Cancer Center of Kansas - Pratt
      • Salina, Kansas, Förenta staterna, 67401
        • Cancer Center of Kansas - Salina
      • Wellington, Kansas, Förenta staterna, 67152
        • Cancer Center of Kansas - Wellington
      • Wichita, Kansas, Förenta staterna, 67214
        • Ascension Via Christi Hospitals Wichita
      • Wichita, Kansas, Förenta staterna, 67208
        • Cancer Center of Kansas-Wichita Medical Arts Tower
      • Wichita, Kansas, Förenta staterna, 67214
        • Cancer Center of Kansas - Wichita
      • Wichita, Kansas, Förenta staterna, 67208
        • Associates In Womens Health
      • Winfield, Kansas, Förenta staterna, 67156
        • Cancer Center of Kansas - Winfield
    • Kentucky
      • Bardstown, Kentucky, Förenta staterna, 40004
        • CommonSpirit Saint Joseph Hospital - Bardstown
      • Corbin, Kentucky, Förenta staterna, 40701
        • Commonwealth Cancer Center-Corbin
      • Lexington, Kentucky, Förenta staterna, 40504
        • Saint Joseph Radiation Oncology Resource Center
      • Lexington, Kentucky, Förenta staterna, 40509
        • CommonSpirit Saint Joseph Medical Center - East Lexington
      • Louisville, Kentucky, Förenta staterna, 40202
        • Jewish Hospital
      • Louisville, Kentucky, Förenta staterna, 40245
        • UofL Health Medical Center Northeast
      • Louisville, Kentucky, Förenta staterna, 40215
        • Saints Mary and Elizabeth Hospital
      • Shepherdsville, Kentucky, Förenta staterna, 40165
        • Jewish Hospital Medical Center South
    • Maine
      • Scarborough, Maine, Förenta staterna, 04074
        • MaineHealth Maine Medical Center- Scarborough
    • Maryland
      • Baltimore, Maryland, Förenta staterna, 21287
        • Johns Hopkins University/Sidney Kimmel Cancer Center
    • Massachusetts
      • Boston, Massachusetts, Förenta staterna, 02215
        • Dana-Farber Cancer Institute
      • Boston, Massachusetts, Förenta staterna, 02115
        • Brigham and Women's Hospital
      • Boston, Massachusetts, Förenta staterna, 02114
        • Massachusetts General Hospital Cancer Center
      • Burlington, Massachusetts, Förenta staterna, 01805
        • Lahey Clinic
    • Michigan
      • Brownstown, Michigan, Förenta staterna, 48183
        • Henry Ford Cancer Institute-Downriver
      • Clinton Township, Michigan, Förenta staterna, 48038
        • Henry Ford Macomb Hospital-Clinton Township
      • Dearborn, Michigan, Förenta staterna, 48126
        • Henry Ford Medical Center-Fairlane
      • Detroit, Michigan, Förenta staterna, 48202
        • Henry Ford Hospital
      • Detroit, Michigan, Förenta staterna, 48201
        • Wayne State University/Karmanos Cancer Institute
      • Farmington Hills, Michigan, Förenta staterna, 48334
        • Weisberg Cancer Treatment Center
      • Novi, Michigan, Förenta staterna, 48377
        • Henry Ford Medical Center-Columbus
      • West Bloomfield, Michigan, Förenta staterna, 48322
        • Henry Ford West Bloomfield Hospital
    • Missouri
      • Bolivar, Missouri, Förenta staterna, 65613
        • Central Care Cancer Center - Bolivar
      • Bonne Terre, Missouri, Förenta staterna, 63628
        • Parkland Health Center-Bonne Terre
      • Branson, Missouri, Förenta staterna, 65616
        • Cox Cancer Center Branson
      • Cape Girardeau, Missouri, Förenta staterna, 63703
        • Saint Francis Medical Center
      • Cape Girardeau, Missouri, Förenta staterna, 63703
        • Mercy Cancer Center - Cape Girardeau
      • Jefferson City, Missouri, Förenta staterna, 65109
        • MU Health Care Goldschmidt Cancer Center
      • Joplin, Missouri, Förenta staterna, 64804
        • Freeman Health System
      • Joplin, Missouri, Förenta staterna, 64804
        • Mercy Hospital Joplin
      • Rolla, Missouri, Förenta staterna, 65401
        • Mercy Clinic-Rolla-Cancer and Hematology
      • Rolla, Missouri, Förenta staterna, 65401
        • Phelps Health Delbert Day Cancer Institute
      • Sainte Genevieve, Missouri, Förenta staterna, 63670
        • Sainte Genevieve County Memorial Hospital
      • Springfield, Missouri, Förenta staterna, 65807
        • CoxHealth South Hospital
      • Springfield, Missouri, Förenta staterna, 65804
        • Mercy Hospital Springfield
      • St Louis, Missouri, Förenta staterna, 63131
        • Missouri Baptist Medical Center
      • St Louis, Missouri, Förenta staterna, 63109
        • Mercy Infusion Center - Chippewa
      • St Louis, Missouri, Förenta staterna, 63141
        • Mercy Hospital Saint Louis
      • Sullivan, Missouri, Förenta staterna, 63080
        • Missouri Baptist Sullivan Hospital
    • Montana
      • Anaconda, Montana, Förenta staterna, 59711
        • Community Hospital of Anaconda
      • Billings, Montana, Förenta staterna, 59101
        • Billings Clinic Cancer Center
      • Billings, Montana, Förenta staterna, 59101
        • Saint Vincent Healthcare
      • Bozeman, Montana, Förenta staterna, 59715
        • Bozeman Health Deaconess Hospital
      • Butte, Montana, Förenta staterna, 59701
        • Saint James Community Hospital and Cancer Treatment Center
      • Great Falls, Montana, Förenta staterna, 59405
        • Great Falls Clinic
      • Great Falls, Montana, Förenta staterna, 59405
        • Benefis Sletten Cancer Institute
      • Helena, Montana, Förenta staterna, 59601
        • Saint Peter's Community Hospital
      • Kalispell, Montana, Förenta staterna, 59901
        • Logan Health Medical Center
      • Missoula, Montana, Förenta staterna, 59802
        • Saint Patrick Hospital - Community Hospital
      • Missoula, Montana, Förenta staterna, 59804
        • Community Medical Center
    • Nebraska
      • Grand Island, Nebraska, Förenta staterna, 68803
        • Nebraska Cancer Specialists/Oncology Hematology West PC
      • Kearney, Nebraska, Förenta staterna, 68847
        • CHI Health Good Samaritan
      • Kearney, Nebraska, Förenta staterna, 68845
        • Fred and Pamela Buffett Cancer Center - Kearney
      • Lincoln, Nebraska, Förenta staterna, 68510
        • Saint Elizabeth Regional Medical Center
      • Omaha, Nebraska, Förenta staterna, 68124
        • Alegent Health Bergan Mercy Medical Center
      • Omaha, Nebraska, Förenta staterna, 68122
        • Alegent Health Immanuel Medical Center
      • Omaha, Nebraska, Förenta staterna, 68130
        • Alegent Health Lakeside Hospital
      • Omaha, Nebraska, Förenta staterna, 68122
        • Hematology and Oncology Consultants PC
      • Papillion, Nebraska, Förenta staterna, 68046
        • Midlands Community Hospital
    • Nevada
      • Las Vegas, Nevada, Förenta staterna, 89106
        • Women's Cancer Center of Nevada
    • New Jersey
      • Camden, New Jersey, Förenta staterna, 08103
        • Cooper Hospital University Medical Center
      • Hackensack, New Jersey, Förenta staterna, 07601
        • Hackensack University Medical Center
      • Voorhees Township, New Jersey, Förenta staterna, 08043
        • MD Anderson Cancer Center at Cooper-Voorhees
    • New Mexico
      • Albuquerque, New Mexico, Förenta staterna, 87106
        • Southwest Gynecologic Oncology Associates Inc
      • Albuquerque, New Mexico, Förenta staterna, 87106
        • University of New Mexico Cancer Center
    • New York
      • New York, New York, Förenta staterna, 10065
        • Memorial Sloan Kettering Cancer Center
    • North Carolina
      • Clinton, North Carolina, Förenta staterna, 28328
        • Southeastern Medical Oncology Center-Clinton
      • Clinton, North Carolina, Förenta staterna, 28328
        • Sampson Radiation Oncology
      • Goldsboro, North Carolina, Förenta staterna, 27534
        • Southeastern Medical Oncology Center-Goldsboro
      • Goldsboro, North Carolina, Förenta staterna, 27534
        • Wayne Memorial Hospital
      • Goldsboro, North Carolina, Förenta staterna, 27534
        • Wayne Radiation Oncology
      • Jacksonville, North Carolina, Förenta staterna, 28546
        • Southeastern Medical Oncology Center-Jacksonville
      • Jacksonville, North Carolina, Förenta staterna, 28546
        • Onslow Memorial Hospital
    • Ohio
      • Beachwood, Ohio, Förenta staterna, 44122
        • UHHS-Chagrin Highlands Medical Center
      • Belpre, Ohio, Förenta staterna, 45714
        • Strecker Cancer Center-Belpre
      • Centerville, Ohio, Förenta staterna, 45459
        • Miami Valley Hospital South
      • Centerville, Ohio, Förenta staterna, 45459
        • Dayton Physicians LLC-Miami Valley South
      • Chillicothe, Ohio, Förenta staterna, 45601
        • Adena Regional Medical Center
      • Cincinnati, Ohio, Förenta staterna, 45220
        • Good Samaritan Hospital - Cincinnati
      • Cincinnati, Ohio, Förenta staterna, 45242
        • Bethesda North Hospital
      • Cincinnati, Ohio, Förenta staterna, 45236
        • Oncology Hematology Care Inc-Kenwood
      • Cincinnati, Ohio, Förenta staterna, 45247
        • TriHealth Cancer Institute-Westside
      • Cincinnati, Ohio, Förenta staterna, 45255
        • TriHealth Cancer Institute-Anderson
      • Cleveland, Ohio, Förenta staterna, 44106
        • Case Western Reserve University
      • Cleveland, Ohio, Förenta staterna, 44195
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, Förenta staterna, 44111
        • Cleveland Clinic Cancer Center/Fairview Hospital
      • Columbus, Ohio, Förenta staterna, 43214
        • Riverside Methodist Hospital
      • Columbus, Ohio, Förenta staterna, 43210
        • Ohio State University Comprehensive Cancer Center
      • Columbus, Ohio, Förenta staterna, 43219
        • The Mark H Zangmeister Center
      • Columbus, Ohio, Förenta staterna, 43214
        • Columbus Oncology and Hematology Associates Inc
      • Columbus, Ohio, Förenta staterna, 43228
        • Doctors Hospital
      • Columbus, Ohio, Förenta staterna, 43213
        • Mount Carmel East Hospital
      • Columbus, Ohio, Förenta staterna, 43215
        • Grant Medical Center
      • Columbus, Ohio, Förenta staterna, 43222
        • Mount Carmel Health Center West
      • Dayton, Ohio, Förenta staterna, 45406
        • Good Samaritan Hospital - Dayton
      • Dayton, Ohio, Förenta staterna, 45409
        • Miami Valley Hospital
      • Dayton, Ohio, Förenta staterna, 45415
        • Miami Valley Hospital North
      • Dayton, Ohio, Förenta staterna, 45415
        • Dayton Physician LLC - Englewood
      • Delaware, Ohio, Förenta staterna, 43015
        • Delaware Health Center-Grady Cancer Center
      • Delaware, Ohio, Förenta staterna, 43015
        • Delaware Radiation Oncology
      • Delaware, Ohio, Förenta staterna, 43015
        • Grady Memorial Hospital
      • Findlay, Ohio, Förenta staterna, 45840
        • Blanchard Valley Hospital
      • Findlay, Ohio, Förenta staterna, 45840
        • Armes Family Cancer Center
      • Findlay, Ohio, Förenta staterna, 45840
        • Orion Cancer Care
      • Franklin, Ohio, Förenta staterna, 45005-1066
        • Atrium Medical Center-Middletown Regional Hospital
      • Franklin, Ohio, Förenta staterna, 45005
        • Dayton Physicians LLC-Atrium
      • Greenville, Ohio, Förenta staterna, 45331
        • Wayne Hospital
      • Greenville, Ohio, Förenta staterna, 45331
        • Dayton Physicians LLC-Wayne
      • Kettering, Ohio, Förenta staterna, 45429
        • Kettering Medical Center
      • Kettering, Ohio, Förenta staterna, 45409
        • Greater Dayton Cancer Center
      • Lancaster, Ohio, Förenta staterna, 43130
        • Fairfield Medical Center
      • Marietta, Ohio, Förenta staterna, 45750
        • Marietta Memorial Hospital
      • Marion, Ohio, Förenta staterna, 43302
        • OhioHealth Marion General Hospital
      • Mayfield Heights, Ohio, Förenta staterna, 44124
        • Hillcrest Hospital Cancer Center
      • Mayfield Heights, Ohio, Förenta staterna, 44124
        • UH Seidman Cancer Center at Landerbrook Health Center
      • Mentor, Ohio, Förenta staterna, 44060
        • UH Seidman Cancer Center at Lake Health Mentor Campus
      • Middletown, Ohio, Förenta staterna, 45042
        • Dayton Physicians LLC-Signal Point
      • Mount Vernon, Ohio, Förenta staterna, 43050
        • Knox Community Hospital
      • Newark, Ohio, Förenta staterna, 43055
        • Licking Memorial Hospital
      • Newark, Ohio, Förenta staterna, 43055
        • Newark Radiation Oncology
      • Portsmouth, Ohio, Förenta staterna, 45662
        • Southern Ohio Medical Center
      • Sidney, Ohio, Förenta staterna, 45365
        • Dayton Physicians LLC-Wilson
      • Springfield, Ohio, Förenta staterna, 45504
        • Springfield Regional Cancer Center
      • Springfield, Ohio, Förenta staterna, 45504
        • Springfield Regional Medical Center
      • Troy, Ohio, Förenta staterna, 45373
        • Upper Valley Medical Center
      • Troy, Ohio, Förenta staterna, 45373
        • Dayton Physicians LLC - Troy
      • Wadsworth, Ohio, Förenta staterna, 44281
        • University Hospitals Sharon Health Center
      • Westerville, Ohio, Förenta staterna, 43081
        • Saint Ann's Hospital
      • Westlake, Ohio, Förenta staterna, 44145
        • UHHS-Westlake Medical Center
      • Zanesville, Ohio, Förenta staterna, 43701
        • Genesis Healthcare System Cancer Care Center
    • Oklahoma
      • Oklahoma City, Oklahoma, Förenta staterna, 73104
        • University of Oklahoma Health Sciences Center
      • Tulsa, Oklahoma, Förenta staterna, 74146
        • Oklahoma Cancer Specialists and Research Institute-Tulsa
    • Oregon
      • Bend, Oregon, Förenta staterna, 97701
        • Saint Charles Health System
      • Clackamas, Oregon, Förenta staterna, 97015
        • Clackamas Radiation Oncology Center
      • Clackamas, Oregon, Förenta staterna, 97015
        • Providence Cancer Institute Clackamas Clinic
      • Coos Bay, Oregon, Förenta staterna, 97420
        • Bay Area Hospital
      • Newberg, Oregon, Förenta staterna, 97132
        • Providence Newberg Medical Center
      • Oregon City, Oregon, Förenta staterna, 97045
        • Providence Willamette Falls Medical Center
      • Portland, Oregon, Förenta staterna, 97213
        • Providence Portland Medical Center
      • Portland, Oregon, Förenta staterna, 97225
        • Providence Saint Vincent Medical Center
    • Pennsylvania
      • Abington, Pennsylvania, Förenta staterna, 19001
        • Jefferson Abington Hospital
      • Allentown, Pennsylvania, Förenta staterna, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Bethlehem, Pennsylvania, Förenta staterna, 18017
        • Lehigh Valley Hospital - Muhlenberg
      • Chadds Ford, Pennsylvania, Förenta staterna, 19317
        • Christiana Care Health System-Concord Health Center
      • Ephrata, Pennsylvania, Förenta staterna, 17522
        • Ephrata Cancer Center
      • Gettysburg, Pennsylvania, Förenta staterna, 17325
        • Adams Cancer Center
      • Hanover, Pennsylvania, Förenta staterna, 17331
        • WellSpan Medical Oncology and Hematology
      • Philadelphia, Pennsylvania, Förenta staterna, 19104
        • University of Pennsylvania/Abramson Cancer Center
      • West Reading, Pennsylvania, Förenta staterna, 19611
        • Reading Hospital
      • York, Pennsylvania, Förenta staterna, 17403
        • WellSpan Health-York Cancer Center
      • York, Pennsylvania, Förenta staterna, 17403
        • WellSpan Health-York Hospital
    • Rhode Island
      • Providence, Rhode Island, Förenta staterna, 02905
        • Women and Infants Hospital
    • South Carolina
      • Boiling Springs, South Carolina, Förenta staterna, 29316
        • Prisma Health Cancer Institute - Spartanburg
      • Charleston, South Carolina, Förenta staterna, 29425
        • Medical University of South Carolina
      • Easley, South Carolina, Förenta staterna, 29640
        • Prisma Health Cancer Institute - Easley
      • Greenville, South Carolina, Förenta staterna, 29605
        • Prisma Health Cancer Institute - Faris
      • Greenville, South Carolina, Förenta staterna, 29607
        • Saint Francis Cancer Center
      • Greenville, South Carolina, Förenta staterna, 29615
        • Prisma Health Cancer Institute - Eastside
      • Greenville, South Carolina, Förenta staterna, 29605
        • Prisma Health Cancer Institute - Butternut
      • Greenville, South Carolina, Förenta staterna, 29601
        • Saint Francis Hospital
      • Greenville, South Carolina, Förenta staterna, 29605
        • Prisma Health Greenville Memorial Hospital
      • Greenville, South Carolina, Förenta staterna, 29601
        • Greenville Health System Cancer Institute-Andrews
      • Greer, South Carolina, Förenta staterna, 29650
        • Prisma Health Cancer Institute - Greer
      • Seneca, South Carolina, Förenta staterna, 29672
        • Prisma Health Cancer Institute - Seneca
    • South Dakota
      • Sioux Falls, South Dakota, Förenta staterna, 57105
        • Avera Cancer Institute
    • Tennessee
      • Chattanooga, Tennessee, Förenta staterna, 37404
        • Memorial Hospital
      • Hixson, Tennessee, Förenta staterna, 37343
        • Pulmonary Medicine Center of Chattanooga-Hixson
      • Ooltewah, Tennessee, Förenta staterna, 37363
        • Memorial GYN Plus
    • Texas
      • Houston, Texas, Förenta staterna, 77030
        • UT MD Anderson Cancer Center
    • Utah
      • Salt Lake City, Utah, Förenta staterna, 84112
        • Huntsman Cancer Institute/University of Utah
      • South Jordan, Utah, Förenta staterna, 84009
        • South Jordan Health Center
    • Virginia
      • Falls Church, Virginia, Förenta staterna, 22042
        • Inova Fairfax Hospital
    • Washington
      • Aberdeen, Washington, Förenta staterna, 98520
        • Providence Regional Cancer System-Aberdeen
      • Anacortes, Washington, Förenta staterna, 98221
        • Cancer Care Center at Island Hospital
      • Bellevue, Washington, Förenta staterna, 98005
        • Swedish Cancer Institute-Eastside Oncology Hematology
      • Bellingham, Washington, Förenta staterna, 98225
        • PeaceHealth Saint Joseph Medical Center
      • Burien, Washington, Förenta staterna, 98166
        • Saint Anne Hospital
      • Centralia, Washington, Förenta staterna, 98531
        • Providence Regional Cancer System-Centralia
      • Edmonds, Washington, Förenta staterna, 98026
        • Swedish Cancer Institute-Edmonds
      • Enumclaw, Washington, Förenta staterna, 98022
        • Saint Elizabeth Hospital
      • Everett, Washington, Förenta staterna, 98201
        • Providence Regional Cancer Partnership
      • Federal Way, Washington, Förenta staterna, 98003
        • Saint Francis Hospital
      • Issaquah, Washington, Förenta staterna, 98029
        • Swedish Cancer Institute-Issaquah
      • Lacey, Washington, Förenta staterna, 98503
        • Providence Regional Cancer System-Lacey
      • Lakewood, Washington, Förenta staterna, 98499
        • Saint Clare Hospital
      • Longview, Washington, Förenta staterna, 98632
        • PeaceHealth Saint John Medical Center
      • Poulsbo, Washington, Förenta staterna, 98370
        • Harrison HealthPartners Hematology and Oncology-Poulsbo
      • Seattle, Washington, Förenta staterna, 98107
        • Swedish Medical Center-Ballard Campus
      • Seattle, Washington, Förenta staterna, 98122
        • Swedish Medical Center-First Hill
      • Seattle, Washington, Förenta staterna, 98195
        • University of Washington Medical Center - Montlake
      • Seattle, Washington, Förenta staterna, 98112
        • Kaiser Permanente Washington
      • Seattle, Washington, Förenta staterna, 98104
        • Minor and James Medical PLLC
      • Seattle, Washington, Förenta staterna, 98104
        • Pacific Gynecology Specialists
      • Seattle, Washington, Förenta staterna, 98109
        • Fred Hutchinson Cancer Center
      • Seattle, Washington, Förenta staterna, 98133
        • University of Washington Medical Center - Northwest
      • Seattle, Washington, Förenta staterna, 98133
        • Women's Cancer Center of Seattle
      • Shelton, Washington, Förenta staterna, 98584
        • Providence Regional Cancer System-Shelton
      • Silverdale, Washington, Förenta staterna, 98383
        • Saint Joseph Medical Center Hematology and Oncology - Silverdale
      • Spokane, Washington, Förenta staterna, 99218
        • Evergreen Hematology and Oncology PS
      • Spokane, Washington, Förenta staterna, 99204
        • MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
      • Spokane Valley, Washington, Förenta staterna, 99216
        • MultiCare Deaconess Cancer and Blood Specialty Center - Valley
      • Tacoma, Washington, Förenta staterna, 98405
        • Northwest Medical Specialties PLLC
      • Tacoma, Washington, Förenta staterna, 98405
        • Franciscan Research Center-Northwest Medical Plaza
      • Vancouver, Washington, Förenta staterna, 98664
        • PeaceHealth Southwest Medical Center
      • Walla Walla, Washington, Förenta staterna, 99362
        • Providence Saint Mary Regional Cancer Center
      • Yakima, Washington, Förenta staterna, 98902
        • North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
      • Yelm, Washington, Förenta staterna, 98597
        • Providence Regional Cancer System-Yelm
    • West Virginia
      • Morgantown, West Virginia, Förenta staterna, 26505
        • Monongalia Hospital
    • Wisconsin
      • Milwaukee, Wisconsin, Förenta staterna, 53226
        • Medical College of Wisconsin
    • Wyoming
      • Cody, Wyoming, Förenta staterna, 82414
        • Big Horn Basin Cancer Center
      • Cody, Wyoming, Förenta staterna, 82414
        • Billings Clinic-Cody
      • Sheridan, Wyoming, Förenta staterna, 82801
        • Welch Cancer Center

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Kvinna

Beskrivning

Inclusion Criteria:

  • Patients must have persistent, recurrent or metastatic squamous cell carcinoma, adenosquamous carcinoma or adenocarcinoma of the cervix with documented disease progression (disease not amendable to curative therapy); NOTE: the following cervical tumors are not eligible: minimal deviation/adenoma malignum, gastric type adenocarcinoma, clear cell carcinoma and mesonephric carcinoma; histologic confirmation of the original primary tumor is required via the pathology report

  • All patents must have measurable disease as defined by RECIST 1.1; measurable disease is defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded); each lesion must be >= 10 mm when measured by computed tomography (CT), magnetic resonance imaging (MRI) or caliper measurement by clinical exam; or >= 20 mm when measured by chest x-ray; lymph nodes must be >= 15 mm in short axis when measured by CT or MRI

  • Patients must have at least one "target" lesion" to be used to assess response on this protocol as defined by RECIST 1.1; tumors within a previously irradiated field will be designated as "non-target" lesions unless progression is documented or a biopsy is obtained to confirm persistence at least 90 days following completion of radiation therapy

  • Appropriate for study entry based on the following diagnostic workup:

    • History/physical examination within 28 days prior to registration

    • Imaging of target lesion(s) within 28 days prior to registration

    • Further protocol-specific assessments:

      • Recovery from adverse effects of recent surgery, radiotherapy or chemotherapy
      • Any other prior therapy directed at the malignant tumor including chemotherapy, biologic/targeted agents and immunologic agents must be discontinued at least three weeks prior to registration
      • Investigation agents must be discontinued for at least 30 days prior to registration
      • Any prior radiation therapy must be completed at least 4 weeks prior to registration
      • At least 4 weeks must have elapsed since any major surgery prior to registration
  • Patients must have had one prior systemic chemotherapeutic regimen for management of persistent, recurrent or metastatic carcinoma of the cervix (e.g.; paclitaxel/cisplatin, paclitaxel/cisplatin/bevacizumab); chemotherapy administered concurrent with primary radiation (e.g.; weekly cisplatin) is not counted as a systemic chemotherapy regimen; adjuvant chemotherapy given following the completion of radiation therapy (or concurrent chemotherapy and radiation therapy) is not counted as a systemic chemotherapy regimen (e.g.; paclitaxel and carboplatin for up to 4 cycles); NOTE: patients who have received more than one prior regimen are NOT eligible

  • Performance status of 0 or 1

  • Absolute neutrophil count (ANC) >= 1,500/ul

  • Platelets >= 100,000/ul

  • Creatinine =< 1.5 x institutional upper limit of normal (ULN) or creatinine clearance (CrCl) >= 40 mL/min using Cockcroft-Gault formula

  • Bilirubin =< 1.5 x ULN

  • Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< 3 x ULN

  • Normal thyroid function testing (thyroid stimulating hormone [TSH]) within 14 days prior to registration

  • The patient or a legally authorized representative must provide study-specific informed consent authorization permitting release of personal health information prior to study entry

Exclusion Criteria:

  • Patients who have had prior therapy with nivolumab or with an anti-PD-1, anti-PD-ligand (L)1, anti-PD-L2, anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibody, or any other antibody or drug specifically targeting T-cell co-stimulation or immune check point pathways

  • History of severe hypersensitivity reaction to any monoclonal antibody

  • Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years

  • Patients with uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure and unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements

  • Patients who are pregnant or nursing; women of child-bearing potential (WOCBP) must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation; WOCBP should use an adequate method to avoid pregnancy for 23 weeks after the last dose of investigational drug; WOCBP must have a negative serum or urine pregnancy test (minimum sensitivity 25 IV/L or equivalent units of human chorionic gonadotropin [HCG]) within 24 hours prior to the start of nivolumab; women must not be breastfeeding

    • Women who are not of childbearing potential (i.e., who are postmenopausal or surgically sterile or have undergone definitive radiation) do not require contraception
    • Women of childbearing potential (WOCBP) is defined as any female who has experienced menarche and who has not undergone surgical sterilization (hysterectomy of bilateral oophorectomy) or who is not postmenopausal; menopause is defined clinically as 12 month amenorrhea in a woman over 45 in the absence of other biological or physiological causes; in addition, women under the age of 55 must have a documented serum follicle stimulating hormone (FSH) level greater than 40 mIU/mL
    • WOCBP receiving nivolumab will be instructed to adhere to contraception for a period of 23 weeks after the last dose of investigational product
    • Should a woman become pregnant or suspect she is pregnant while she is participating in this study, she should inform the treating physician immediately
  • Patients with known brain metastases or leptomeningeal metastases are excluded unless the following conditions are met:

    • Metastases have been treated and there is no magnetic resonance imaging (MRI) evidence of progression for at least 4 weeks after treatment is complete (must be confirmed within 28 days prior to the first dose of nivolumab administration)
    • There must also be no requirement for immunosuppressive doses of systemic corticosteroids (> 10 mg/day prednisone equivalents) for at least 2 weeks prior to study drug administration
  • Patients should be excluded if they have known history of testing positive for human immunodeficiency virus (HIV) or known acquired immunodeficiency syndrome (AIDS)

    • Patients should be excluded if they have a positive test for hepatitis B virus surface antigen (HBV sAg) or hepatitis C virus ribonucleic acid (HCV antibody) indicating acute or chronic infection
  • Patients with active autoimmune disease or history of autoimmune disease that might recur, which may affect vital organ function or require immune suppressive treatment including systemic corticosteroids, should be excluded; these include but are not limited to patients with a history of immune related neurologic disease, multiple sclerosis, autoimmune (demyelinating) neuropathy, Guillain-Barre syndrome, myasthenia gravis; systemic autoimmune disease such as systemic lupus erythematosus (SLE), connective tissue diseases, scleroderma, inflammatory bowel disease (IRB), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, or phospholipid syndrome should be excluded; patient with vitiligo, endocrine deficiencies including thyroiditis managed with replacement hormones including physiologic corticosteroids are eligible; patients with rheumatoid arthritis and other arthropathies, Sjogren's syndrome and psoriasis controlled with topical medication and patients with positive serology, such as antinuclear antibodies (ANA), anti-thyroid antibodies should be evaluated for the presence of target organ involvement and potential need for systemic treatment but should otherwise be eligible

    • NOTE: patients are permitted to enroll if they have vitiligo, type I diabetes mellitus, residual hypothyroidism due to autoimmune condition only requiring hormone replacement, psoriasis not requiring systemic treatment, or conditions not expected to recur in the absence of an external trigger (precipitating event)
  • Patients should be excluded if they have a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 14 days of study drug administration; inhaled or topical steroids and adrenal replacement doses =< 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease; patients are permitted to use topical, ocular, intra-articular, intranasal, and inhalational corticosteroids (with minimal systemic absorption); physiologic replacement doses of systemic corticosteroids are permitted, even if =< 10 mg/day prednisone equivalents; a brief course of corticosteroids for prophylaxis (e.g., contrast dye allergy) or for treatment of non-autoimmune conditions (e.g., delayed-type hypersensitivity reaction caused by contact allergen) is permitted

  • Patients who have had evidence of active or acute diverticulitis, intra-abdominal abscess, abdominal/pelvic fistula, gastrointestinal perforation, gastrointestinal (GI) obstruction and/or who require parenteral hydration and/or nutrition

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Treatment (nivolumab)

Patients receive nivolumab IV over approximately 60 minutes every 2 weeks for a maximum of 46 doses over 92 weeks in the absence of disease progression or unacceptable toxicity.

Correlative studies

Given IV

Andra namn:
  • BMS-936558
  • MDX-1106
  • NIVO
  • ONO-4538
  • Opdivo
  • CMAB819
  • Nivolumab Biosimilar CMAB819
  • MDX 1106
  • MDX1106
  • BMS 936558
  • ABP 206
  • Nivolumab Biosimilar ABP 206
  • BCD-263
  • Nivolumab Biosimilar BCD-263
  • BMS936558
  • ONO 4538
  • ONO4538

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Objective Tumor Response as Assessed by RECIST 1.1 Criteria
Tidsram: The average of study treatment time was 3.8 months.

Proportion of participants with objective tumor response. Objective tumor response is defined as complete or partial tumor response assessed by RECIST 1.1.

The average of study treatment time was 3.8 months.
Adverse Events (Grade 3 or Higher) During Treatment Period as Assessed by CTCAE Version 4
Tidsram: Within 100 days of last protocol treatment

Number of participants with a maximum grade of 3 or higher during treatment period. Adverse events are graded and categorized using CTCAE v4.0.

Within 100 days of last protocol treatment

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Progression-free Survival
Tidsram: Time from study entry to time of progression or death, whichever occurs first, up to 5 years of follow-up.

Progression-free survival is the period of time from study entry to time of disease progression, death or date of last contact, whichever occurs first. Progression is assessed by RECIST 1.1.

Time from study entry to time of progression or death, whichever occurs first, up to 5 years of follow-up.
Overall Survival
Tidsram: Time from study entry to time of death or the date of last contact, up to 5 years of follow-up

Overall survival is defined as the duration of time from study entry to time of death or the date of last contact.

Time from study entry to time of death or the date of last contact, up to 5 years of follow-up

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Tumor Expressions of PD-1 and PD-L1 in Tumor Infiltrating Lymphocytes and Cervical Cancer Cells
Tidsram: Up to 5 years

Spearman's correlation coefficient will be used to explore the associations of tumor expressions of PD-L1, PD-1 and other interested biomarkers with tumor response. Cox proportional hazards (PH) model will be utilized to evaluate the associations of these tumor expressions with PFS and OS. These expressions may also be dichotomized into high versus low values (cut at the median). Log-rank tests will be used to assess the associations of these dichotomized tumor expressions with PFS and OS. The corresponding hazard rations will be estimated by Cox PH models.

Up to 5 years
Immune Infiltration Related Biomarkers (i.e., CD4+, CD8+, FoxP3) in Tumor Specimens
Tidsram: Up to 5 years

Immune infiltration related biomarkers (i.e., CD4+, CD8+, FoxP3) in tumor specimens will be associated with objective tumor response, PFS and OS in nivolumab-treated patients.

Up to 5 years
Change in the Immune Response to HPV 16/18/31/35/45 E7 Antigen in Peripheral Blood Lymphocytes and Serum
Tidsram: Baseline to up to 5 years

Wilcoxon signed rank test (for interval or ordinal data) or McNemar's test (for binary data) may be utilized to examine whether the study treatment will change immune response to HPV 16/18/31/35/45 E7 antigen in peripheral blood lymphocytes and serum by changes in the measures of pre- and post-treatment immune response to HPV 16/18/31/35/45 E7.

Baseline to up to 5 years
Change in the CTC Count
Tidsram: Baseline to up to 12 weeks

Change in the CTC count and whether the CTC count is associated with objective response, PFS and OS in nivolumab-treated patients will be evaluated.

Baseline to up to 12 weeks

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Samarbetspartners

Utredare

  • Huvudutredare: Alessandro D Santin, NRG Oncology

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

18 maj 2015

Primärt slutförande (Faktisk)

5 mars 2019

Avslutad studie (Beräknad)

30 mars 2027

Studieregistreringsdatum

Först inskickad

2 oktober 2014

Först inskickad som uppfyllde QC-kriterierna

2 oktober 2014

Första postat (Beräknad)

6 oktober 2014

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

18 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

16 november 2026

Senast verifierad

1 september 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • NCI-2014-02021
  • U10CA180868 (U.S.S. NIH-anslag/kontrakt)
  • NCI-2014-02021 (Registeridentifierare: CTRP (Clinical Trial Reporting Program))
  • PNRG-GY002_A01PAMDREVW01
  • NRG-GY002 (Annan identifierare: CTEP)
  • NRG-GY002
  • NRG-GY002 (Annan identifierare: NRG Oncology)

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .